Candidiasis Market, by Drug Class (Azoles, Echinocandins, Polyenes, and Flucytosine), by Type (Candida Infections of the Mouth, Throat, and Esophagus, Vaginal Candidiasis, and Invasive/Systemic Candidiasis), by Route of Administration (Oral, Parenteral, a

Candidiasis Market, by Drug Class (Azoles, Echinocandins, Polyenes, and Flucytosine), by Type (Candida Infections of the Mouth, Throat, and Esophagus, Vaginal Candidiasis, and Invasive/Systemic Candidiasis), by Route of Administration (Oral, Parenteral, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Candidiasis is treated using various treatment options such as oral medication, injection, and ointments. The condition is usually treated using over-the-counter antifungal medicines and also specific prescription-based antifungal medicines. Increasing consumer awareness about candidiasis and growing number of treatment options are major factors that are fueling growth of the candidiasis market.
Market Dynamics
The global candidiasis market is expected to witness significant growth, owing to increasing research for development of novel medications showcasing broad-spectrum antifungal activity against invasive fungal infections caused due to Candida albicans. For instance, in October 2018, researchers at the American Society for Microbiology identified a compound alexidine dihydrochloride, which has the highest antifungal and anti-biofilm activity against a diverse range of fungal pathogens, thus having a greater potential for use as a pan-antifungal drug.
However, easy access to alternative treatment methods such as over-the-counter treatments and others are expected to hinder the market growth.
Key features of the study:
This report provides in-depth analysis of the global candidiasis market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global candidiasis market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc., and Pfizer, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global candidiasis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global candidiasis market

Detailed Segmentation:
Global Candidiasis Market, By Drug Class:
Azoles
Echinocandins
Polyenes
Flucytosine
Global Candidiasis Market, By Type:
Candida infections of the mouth, throat, and esophagus
Vaginal candidiasis
Invasive/systemic candidiasis
Global Candidiasis Market, By Route of Administration:
Oral
Parenteral
Topical
Global Candidiasis Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Candidiasis Market, By Region:
North America
By Drug Class:
Azoles
Echinocandins
Polyenes
Flucytosine
By Type:
Candida infections of the mouth, throat, and esophagus
Vaginal candidiasis
Invasive/systemic candidiasis
By Route of Administration:
Oral
Parenteral
Topical
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Drug Class:
Azoles
Echinocandins
Polyenes
Flucytosine
By Type:
Candida infections of the mouth, throat, and esophagus
Vaginal candidiasis
Invasive/systemic candidiasis
By Route of Administration:
Oral
Parenteral
Topical
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Class:
Azoles
Echinocandins
Polyenes
Flucytosine
By Type:
Candida infections of the mouth, throat, and esophagus
Vaginal candidiasis
Invasive/systemic candidiasis
By Route of Administration:
Oral
Parenteral
Topical
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Class:
Azoles
Echinocandins
Polyenes
Flucytosine
By Type:
Candida infections of the mouth, throat, and esophagus
Vaginal candidiasis
Invasive/systemic candidiasis
By Route of Administration:
Oral
Parenteral
Topical
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Class:
Azoles
Echinocandins
Polyenes
Flucytosine
By Type:
Candida infections of the mouth, throat, and esophagus
Vaginal candidiasis
Invasive/systemic candidiasis
By Route of Administration:
Oral
Parenteral
Topical
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
GCC
Israel
Rest of Middle East
Africa
By Drug Class:
Azoles
Echinocandins
Polyenes
Flucytosine
By Type:
Candida infections of the mouth, throat, and esophagus
Vaginal candidiasis
Invasive/systemic candidiasis
By Route of Administration:
Oral
Parenteral
Topical
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Basilea Pharmaceutica Ltd.*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Astellas Pharma Inc.
Grupo Ferrer Internacional, S.A.
Pacgen Life Science Corporation
NovaDigm Therapeutics, Inc.
Cidara Therapeutics, Inc.
Amplyx Pharmaceuticals Inc.
Pfizer, Inc.
“*” marked represents similar segmentation in other categories in the respective section.